Most Recent

image: Gene Therapy for Brain Disease

Gene Therapy for Brain Disease

By | May 16, 2012

Delivering a missing enzyme to the brains of paralyzed children with a rare, life-threatening neurological disease restores movement and builds muscle mass.

0 Comments

image: Does Education Boost Health?

Does Education Boost Health?

By | May 15, 2012

An examination of Swedish health and educational records suggests that more schooling results in healthier adults.

2 Comments

image: Bionic Eye Sees the Light

Bionic Eye Sees the Light

By | May 15, 2012

A light-powered retinal implant restores vision in rats.

0 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

image: New Algerian Research Center

New Algerian Research Center

By | May 14, 2012

Algeria is set to build the first HIV/AIDS research center in Africa.

2 Comments

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

image: Death by Lab-Acquired Infection?

Death by Lab-Acquired Infection?

By | May 8, 2012

A researcher dead from a meningococcal infection may have acquired it in his laboratory.

6 Comments

image: Gene Signaling by Remote

Gene Signaling by Remote

By | May 7, 2012

Nanoparticles in mice can be switched on to activate insulin production using a radio signal.

0 Comments

image: Doubled Gene Boosted Brain Power

Doubled Gene Boosted Brain Power

By | May 7, 2012

Human-specific duplications of a gene involved in brain development may have contributed to our species’ unique intelligence.

6 Comments

image: First Drug from GM Plant Approved

First Drug from GM Plant Approved

By | May 4, 2012

A human enzyme grown in carrot cells will treat patients with Gaucher disease.

10 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech